Dr. Aguayo-Hiraldo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4650 Sunset blvd
MS54
Los Angeles, CA 90027Phone+1 323-361-4755- Is this information wrong?
Summary
- I am currently the medical director for the Transplant and Cellular Therapy section of the Cancer and Blood Disorders Institute at CHLA. My clinical interest includes stem cell transplants for non-malignant disorders, specifically immune deficiencies or disorders of immune dysregulation. My research focused on equitable access to cellular therapy and prevention/treatment of GVHD & TMA.
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2013 - 2016
- University of South Florida MorsaniResidency, Internal Medicine/Pediatrics, 2009 - 2013
- San Juan Bautista School of MedicineClass of 2009, MD, Cum Laude
Certifications & Licensure
- CA State Medical License 2018 - 2025
- TX State Medical License 2016 - 2020
- NM State Medical License 2013 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Development of a Safety Surveillance Plan for The Academic Medicine Sponsor Performing First in Human Cellular Therapy Clinical Trials: A Report from the Consortium fo...Adams, C., Michlitsch, J., Chen, K., Hossain, M., Davis, A., Park, J., Gardner, R., Keller, M., Aguayo-Hiraldo, P., Verneris, M.> ;Transplantation and Cellular Therapy. 2024 Mar 4
- Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis.Akahoshi, Y., Spyrou, N., Hoepting, M., Aguayo-Hiraldo, P., Ayuk, F., Chanswangphuwana, C., Choe, H., Eder, M., Etra, A., Grupp, S., Hexner, E., Hogan, W., Kitko, C., ...> ;Blood Advances. 2024 Feb 7
- A Day 14 Endpoint for Acute GVHD Clinical Trials.Spyrou, N., Akahoshi, Y., Kowalyk, S., Morales, G., Beheshti, R., Aguayo-Hiraldo, P., Al Malki, M., Ayuk, F., Bader, P., Baez, J., Capellini, A., Choe, H., DeFilipp, Z...> ;Transplantation and Cellular Therapy. 2024 Feb 4
- Join now to see all
Press Mentions
- 5 Reasons It’s Important for People of Color to Take Part in Clinical TrialsSeptember 30th, 2023
Professional Memberships
- Member
- Member
- Member
- American Society for Blood and marrow Transplantation-ASBMTMember
- American Society Pediatric Hematology and Oncology- ASPHOMember
Other Languages
- Spanish
Hospital Affiliations
- Children's Hospital Los AngelesLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: